Santen R J, Samojlik E, Wells S A
J Clin Endocrinol Metab. 1980 Sep;51(3):473-7. doi: 10.1210/jcem-51-3-473.
Aminoglutethimide (AG) is a potent inhibitor of aromatization in placental microsomes and in peripheral tissues in postmenopausal women. Aromatase inhibitors have been used to block estrogen production and induce breast tumor regression in rodents. To inhibit ovarian estrogen production, we administered various doses of AG and its highly potent D-stereoisomer to premenopausal women with breast carcinoma. However, at no dose level did AG consistently lower estrone and estradiol concentrations in plasma below those observed in normal menstruating women. Uniform increments in LH and FSH were also not observed. Only during the luteal phase were the levels of estradiol (but not estrone) significantly suppressed. These observations are best explained by the possibility that aromatase enzymes in the ovary, as opposed to those in the placenta and in peripheral tissues, are partially resistant to the effects of AG.
氨鲁米特(AG)是绝经后女性胎盘微粒体和外周组织中芳香化作用的强效抑制剂。芳香化酶抑制剂已被用于阻断雌激素生成并诱导啮齿动物的乳腺肿瘤消退。为抑制卵巢雌激素生成,我们对绝经前乳腺癌女性施用了不同剂量的AG及其高效D - 立体异构体。然而,在任何剂量水平下,AG均未能持续将血浆中的雌酮和雌二醇浓度降低至低于正常月经女性所观察到的水平。促黄体生成素(LH)和促卵泡生成素(FSH)也未出现一致的升高。仅在黄体期,雌二醇水平(而非雌酮)受到显著抑制。这些观察结果最好的解释是,与胎盘和外周组织中的芳香化酶相比,卵巢中的芳香化酶对AG的作用具有部分抗性。